Search All News
Dr. Hershman will begin her six-year term as co-chair in the Spring of 2025.
The award recognizes Dr. Dalla-Favera's over 40-year career working to advance scientific understanding of lymphoma and cancer genetics.
Tannishtha Reya, PhD, is establishing the new Irving Cancer Drug Discovery Program, devoted to helping faculty accelerate research discoveries in their labs to the clinic.
The awardees are proposing innovative clinical trials that aim to advance treatment and interventions for multiple areas of health and medicine.
Source:CUIMC NewsroomApril 25, 2022
Congratulations to HICCC members, Adam Bass, MD, and Robert Schwabe, MD, PhD, for their election to the Association of American Physicians.
- January 26, 2022
Michael Shen, PhD, the Arthur J. Antenucci Professor of Medical Sciences, has been elected to the 2021 class of new fellows of the American Association for the Advancement of Science (AAAS).
- January 24, 2022
Dr. Barbara Pro, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at the Herbert Irving Comprehensive Cancer Center (HICCC).
- December 15, 2021
The new Center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.